These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2165423)

  • 1. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder.
    Pfohl B; Black D; Noyes R; Kelley M; Blum N
    Biol Psychiatry; 1990 Jul; 28(1):41-6. PubMed ID: 2165423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
    Bastani B; Arora RC; Meltzer HY
    Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
    Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
    Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
    Kim SW; Dysken MW; Pandey GN; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
    Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
    Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma of depressed patients enhances platelet imipramine binding.
    Marazziti D; Rotondo A; Perugi G; Placidi GF; Cassano GB; Pacifici GM
    Biol Psychiatry; 1989 Apr; 25(7):985-7. PubMed ID: 2541806
    [No Abstract]   [Full Text] [Related]  

  • 10. Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder.
    Kim SW; Grant JE
    Psychiatry Res; 2001 Nov; 104(3):205-12. PubMed ID: 11728609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased platelet 3H-imipramine binding in Down's syndrome.
    Tang SW; Berg JM; Bruni J; Davis A
    Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tridimensional Personality Questionnaire in obsessive-compulsive disorder.
    Richter MA; Summerfeldt LJ; Joffe RT; Swinson RP
    Psychiatry Res; 1996 Dec; 65(3):185-8. PubMed ID: 9029667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased platelet 3H-imipramine binding in Parkinson's disease.
    Schneider LS; Chui HC; Severson JA; Sloane RB
    Biol Psychiatry; 1988 Jul; 24(3):348-51. PubMed ID: 2840980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine binding to platelets of children with attention deficit disorder with hyperactivity.
    Weizman A; Bernhout E; Weitz R; Tyano S; Rehavi M
    Biol Psychiatry; 1988 Mar; 23(5):491-6. PubMed ID: 2830919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
    Marazziti D; Hollander E; Lensi P; Ravagli S; Cassano GB
    Psychiatry Res; 1992 Apr; 42(1):41-51. PubMed ID: 1603880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between platelet imipramine binding sites and suicide.
    Lester D
    Pharmacopsychiatry; 1991 Nov; 24(6):232. PubMed ID: 1667437
    [No Abstract]   [Full Text] [Related]  

  • 20. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
    Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R
    Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.